Advertising Survey

We would like your input on how advertising is currently used in the site.

Please take this short survey to help us out.

Hide this message

Bardet-Biedl Syndrome

This PatientPlus article is written for healthcare professionals so the language may be more technical than the condition leaflets. You may find the abbreviations list helpful.

It is named after Georges Louis Bardet, a French physician (born 1885) and after Artur Biedl, a Hungarian pathologist and endocrinologist (born 1869).

Epidemiology

Bardet-Biedl syndrome (BBS) is a familial condition.

  • Bedouins and the Arab population of Kuwait have an incidence of 1:13,500.
  • A high incidence (1:17,500) is also found in Newfoundland. 1:160,000 elsewhere.
  • Ratio male:female approximately 1·3:1

Although it had been originally thought to be a recessive disorder, it has been demonstrated that some forms of Bardet-Biedl syndrome require recessive mutations in 1 of the 6 loci, plus an additional mutation in a second locus.1 This has been called 'triallelic inheritance', or 'recessive inheritance with a modifier of penetrance'.

Fourteen forms have been identified with differing phenotypes:2

  • There are only subtle differences among Bardet-Biedl families with BBS1, BBS2, or BBS4 forms. The most obvious feature is that affected offspring in the BBS1 category are taller than their parents. Affected subjects in the BBS2 and BBS4 groups were significantly shorter than their parents.
  • BBS3 patients have polydactyly limited to the lower limbs, average IQ, and obesity reversible by calorie restriction and/or exercise.
  • In reported case series of BBS 5 no patients had polydactyly, but all had brachydactyly and/or syndactyly. All had severe visual impairment with retinal macular changes, and there was hypogonadism in the 2 males examined.

(Laurence-Moon-Biedl syndrome and Laurence-Moon-Biedl-Bardet syndrome are no longer considered valid terms, because the patients of Laurence and Moon had paraplegia, but no polydactyly and obesity, which are the main characteristics of the Bardet-Biedl syndrome.)

Laurence-Moon syndrome is a separate entity.

Clinical features3

  • Growth and development: Mental and growth retardation
  • Behaviour and performance: Poor visual acuity and blindness
  • Eyes: Rod-cone dystrophy (sometimes called atypical retinitis pigmentosa), myopia, strabismus, and cataracts
  • Hand and foot: Polydactyly, syndactyly or brachydactyly
  • Cardiovascular system: Hypertrophy of interventricular septum and left ventricle and dilated cardiomyopathy
  • Gastrointestinal system: Hepatic fibrosis, central obesity and diabetes mellitus
  • Urogenital system: Hypogonadism, renal failure,4 urogenital sinuses, ectopic urethra, uterus duplex, septate vagina, and hypoplasia of the uterus, ovaries, and fallopian tubes.

Differential diagnosis

Management

There are no specific treatments for the characteristics associated with Bardet-Biedl syndrome.

  • As vision worsens, individuals will benefit from the use of low-vision aids and orientation as well as from mobility training.
  • To manage the complications of renal disease, every individual with the disorder should be examined by a renal physician.

Prognosis

Prognosis is very poor where renal failure occurs.


Document references

  1. Katsanis N, Beales PL, Woods MO, et al; Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat Genet. 2000 Sep;26(1):67-70. [abstract]
  2. Bardet Biedl Syndrome, Online Mendelian Inheritance in Man (OMIM).
  3. Beales PL, Elcioglu N, Woolf AS, et al; New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet. 1999 Jun;36(6):437-46. [abstract]
  4. O'Dea D, Parfrey PS, Harnett JD, et al; The importance of renal impairment in the natural history of Bardet-Biedl syndrome. Am J Kidney Dis. 1996 Jun;27(6):776-83. [abstract]

Internet and further reading

Acknowledgements

EMIS is grateful to Dr Hayley Willacy for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.
Document ID: 1843
Document Version: 22
Document Reference: bgp1347
Last Updated: 21 Apr 2009
Provide feedback